Title | Introducing Ruthenium Brachytherapy in UZ Leuven |
Abstract Nr. | 3015 |
Purpose | To introduce Ruthenium Brachytherapy at the UZ Leuven hospitals to improve the local treatment of uveal and conjunctival ocular tumors. |
Methods | Ruthenium brachytherapy has been used for 3 decades now in European ocular oncology centers, to treat small and middle sized melanomas. Building on these experiences, we introduce this state-of-the-art treatment with local recurrence of 5% and limited radiation retinopathy. |
Results | The implications for treatment of Ruthenium brachytherapy, with a longer hospital stay than Strontium brachytherapy, follow-up, and safety protocols will be discussed in the presentation. |
Conclusion | Introducing Ruthenium brachytherapy in Belgium for the treatment of ocular tumors, expands the range of tumors that can be treated locally, with a minimum of complications. |
Conflict of interest | No |
Last name | MISSOTTEN |
Initials | G |
Department | Dept Ophthalmology, Catholic University Leuven |
City | Leuven |
Last name | Van Ginderdeuren |
Initials | R |
Department | Dept Ophthalmology, Catholic University Leuven |
City | Leuven |
Last name | Clément |
Initials | P |
Department | Dept Medical Oncology, Catholic University Leuven |
City | Leuven |
Last name | Vanden Bempt |
Initials | I |
Department | Dept Medical Genetics, Catholic University Leuven |
City | Leuven |
Last name | Van Limbergen |
Initials | E |
Department | Dept Radiotherapy, Catholic University Leuven |
City | Leuven |
Last name | Van Calster |
Initials | J |
Department | Dept Ophthalmology, Catholic University Leuven |
City | Leuven |